Technology | 2016.04.13
HuMurine Technologies Awarded $299,956 Grant from the National Cancer Institute to Evaluate Immunotherapies in “Humanized” Immune System Mice
Grant awarded under the Small Business Innovative Research (SBIR) Program to establish PDX/Humanized mouse platform to screen anti-cancer immunotherapies in patient-derived tumors using a novel human immune system mouse
(PRWeb April 12, 2016)
Read the full story at http://www.prweb.com/releases/2016/03/prweb13265364.htm
For more information, please visit
http://www.prweb.com/releases/2016/03/prweb13265364.htm
